Targeting high risk patients for vascular screening is just as effective as screening everyone aged 40 to 74 - the current NHS strategy - and is more cost effective, say Cambridge University researchers.
They looked at data on 17,000 patients, comparing universal vascular screening with six other strategies. These included targeting patients aged 50 to 74, patients who were overweight, or those who scored badly in a “heart disease risk questionnaire”. The researchers said universal screening may be unrealistic in “increasingly resource constrained health systems”.
Read the study at BMJ.